Copyright
©The Author(s) 2019.
World J Gastroenterol. Aug 7, 2019; 25(29): 3972-3984
Published online Aug 7, 2019. doi: 10.3748/wjg.v25.i29.3972
Published online Aug 7, 2019. doi: 10.3748/wjg.v25.i29.3972
Figure 2 Results of MEG3 in the diagnosis of colorectal cancer.
A: Serum maternally expressed gene 3 levels in the sample of 1 d and 1 mo after surgery; B: Receiver-operator characteristic curve for colorectal cancer detection. All data were repeated three times; bP < 0.01. 1 d: The 1st d after surgical removal of the tumor; 1 mo: The 30th d after surgical removal of the tumor; ROC: Receiver-operating characteristic curve; AUC: Area under curve; MEG3: Maternally expressed gene 3.
- Citation: Wang W, Xie Y, Chen F, Liu X, Zhong LL, Wang HQ, Li QC. LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer. World J Gastroenterol 2019; 25(29): 3972-3984
- URL: https://www.wjgnet.com/1007-9327/full/v25/i29/3972.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i29.3972